Keywords: sirolimus, switch, option, cyclosporine, patients, american, home

Sirolimus a switch option for cyclosporine patients

Article | 28 May 1999

American Home Products' Rapamune (sirolimus), a macrocyclic lactoneimmunosuppressant that interrupts cytokine-driven T cell proliferation, has been shown to improve outcomes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Rapamune

sirolimus

Cyclosporine

Neoral

Restasis

Go to drug listing